The Methodist Hospital names new Chair for Department of Cardiovascular Surgery and Chief of CardiacHouston, TX - 2/21/2008
The Methodist Hospital filled two new leadership positions in its department of cardiovascular surgery today. Dr. Alan Lumsden, a vascular surgeon, was appointed as the new chairman of the department of cardiovascular surgery
Boundaries between cardiovascular surgery and cardiology are growing increasingly blurred, Lumsden said. Many conditions that used to be treated with large open surgeries are, fortunately, getting smaller and much easier on the patients. At the Methodist DeBakey Heart and Vascular Center, we are going to continue building on our legacy of innovation founded in the extraordinary work of Dr. Michael DeBakey, who invented many of the life-saving surgeries in practice today, and who continues to support change toward less invasive techniques.
Lumsden is recognized worldwide for his research and minimally invasive approach to treatment of abdominal and thoracic aneurysms, which until recently was one of the most complicated surgeries known. He also is known for his expertise in stenting and endarterectomy in carotid arterial disease, renovascular hypertension, diseases of the aorta and minimally invasive therapy in venous disease. His research interests are in the development of newer methods of minimally invasive therapy and the prevention of restenosis, and his lab holds more than $5 million in NIH funding.
An active research program attracts the kind of physicians who have inquiring minds, who want to find better ways to do things, who want to figure out how to move to the next level, said Lumsden, who came to Houston from Emory University School of Medicine in Atlanta. Expansion of our current research programs is one way we plan to grow to provide the best care possible for our patients.
Dr. Michael Reardon, professor of cardiothoracic surgery at Weill Cornell Medical College, was named chief of the division of cardiac surgery at Methodist. Reardon is widely known for his bold, innovative surgical treatment for patients with cardiac tumors. His research in autotransplantation has provided patients from across the world hope and healing in times of desperate circumstances. Dr. Reardons additional research includes adult cardiac surgery, cardiac valve disease and thoracic surgical education. He is also a clinical professor of surgery at M.D. Anderson Cancer Center.
Dr. Reardon is also known for his devotion to education, having trained many heart surgeons during his career. He will work with Dr. Lumsden to build Methodists legacy as one of the nations top destinations for cardiovascular education.
Together, Drs. Lumsden and Reardon have pioneered a new, minimally-invasive surgical procedure to repair aneurysms of the aortic arch and ascending aorta. This hybrid approach combines minimally-invasive surgical bypass techniques with the thoracic stent graft, which was approved by the FDA in 2005 based on research conducted at Methodist by Dr. Lumsden.
Methodist is honored to have such a talented, respected and innovative team to lead the cardiovascular department, said Ron Girotto, president and CEO of The Methodist Hospital System. These physicians, brilliant leaders in their specialties, will lead Methodist and the department of cardiovascular surgery with compassion for our patients and excellence in patient care, research and education.
For more on the Methodist DeBakey Heart and Vascular Center, please see www.debakeyheartcenter.com.